Leo Bastiaens

420 total citations
27 papers, 295 citations indexed

About

Leo Bastiaens is a scholar working on Clinical Psychology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Leo Bastiaens has authored 27 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Clinical Psychology, 10 papers in Psychiatry and Mental health and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Leo Bastiaens's work include Child and Adolescent Psychosocial and Emotional Development (12 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Pharmaceutical studies and practices (5 papers). Leo Bastiaens is often cited by papers focused on Child and Adolescent Psychosocial and Emotional Development (12 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Pharmaceutical studies and practices (5 papers). Leo Bastiaens collaborates with scholars based in United States and United Kingdom. Leo Bastiaens's co-authors include Michael Davidson, Kenneth L. Davis, Bonnie M. Davis, Belinda Davis, K L Davis, Michael Davidson and Timothy Ryan and has published in prestigious journals such as American Journal of Psychiatry, Endocrinology and Metabolism Clinics of North America and European Psychiatry.

In The Last Decade

Leo Bastiaens

26 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo Bastiaens United States 10 125 117 61 61 41 27 295
Grace Hennessy United States 7 80 0.6× 143 1.2× 28 0.5× 73 1.2× 92 2.2× 10 310
Nicholas W. Carrellas United States 10 115 0.9× 156 1.3× 41 0.7× 89 1.5× 41 1.0× 17 345
S Pirzada Sattar United States 11 99 0.8× 132 1.1× 33 0.5× 26 0.4× 52 1.3× 24 390
F. Tuna Burgut United States 10 116 0.9× 156 1.3× 43 0.7× 108 1.8× 40 1.0× 15 385
Sang‐Keun Chung South Korea 12 149 1.2× 148 1.3× 38 0.6× 23 0.4× 24 0.6× 28 373
Deborah R. Simkin United States 8 130 1.0× 66 0.6× 37 0.6× 26 0.4× 56 1.4× 19 313
Andrea Johansson Capusan Sweden 11 135 1.1× 152 1.3× 29 0.5× 58 1.0× 61 1.5× 28 379
S Shapiro United States 3 154 1.2× 76 0.6× 39 0.6× 29 0.5× 18 0.4× 5 402
Aske Astrup Denmark 9 142 1.1× 158 1.4× 29 0.5× 74 1.2× 24 0.6× 11 405
Richard H. Workman United States 12 148 1.2× 205 1.8× 38 0.6× 61 1.0× 26 0.6× 26 402

Countries citing papers authored by Leo Bastiaens

Since Specialization
Citations

This map shows the geographic impact of Leo Bastiaens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Bastiaens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Bastiaens more than expected).

Fields of papers citing papers by Leo Bastiaens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Bastiaens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Bastiaens. The network helps show where Leo Bastiaens may publish in the future.

Co-authorship network of co-authors of Leo Bastiaens

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Bastiaens. A scholar is included among the top collaborators of Leo Bastiaens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Bastiaens. Leo Bastiaens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bastiaens, Leo, et al.. (2018). Treatment of Adult ADHD without Stimulants: Effectiveness in A Dually Diagnosed Correctional Population. Psychiatric Quarterly. 90(1). 41–46. 4 indexed citations
2.
Bastiaens, Leo, et al.. (2017). Comparison of the Adult ADHD Self Report Scale Screener for DSM-IV and DSM-5 in a Dually Diagnosed Correctional Population. Psychiatric Quarterly. 89(2). 505–510. 13 indexed citations
3.
Bastiaens, Leo, et al.. (2017). The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a Screening Tool. Psychiatric Quarterly. 89(1). 111–115. 30 indexed citations
4.
Bastiaens, Leo, et al.. (2016). Abuse of Gabapentin is Associated with Opioid Addiction. Psychiatric Quarterly. 87(4). 763–767. 62 indexed citations
5.
Bastiaens, Leo, et al.. (2014). The 12 Item W.H.O.D.A.S. as Primary Self Report Outcome Measure in a Correctional Community Treatment Center for Dually Diagnosed Patients. Psychiatric Quarterly. 86(2). 219–224. 7 indexed citations
6.
Bastiaens, Leo. (2011). Improvement in Global Psychopathology Increases Quality of Life During Treatment of ADHD with Atomoxetine or Stimulants. Psychiatric Quarterly. 82(4). 303–308. 5 indexed citations
7.
Bastiaens, Leo. (2008). Both Atomoxetine and Stimulants Improve Quality of Life in an ADHD Population Treated in a Community Clinic. Psychiatric Quarterly. 79(2). 133–137. 19 indexed citations
8.
Bastiaens, Leo. (2008). A Non-randomized, Open Study with Aripiprazole and Ziprasidone for the Treatment of Aggressive Behavior in Youth in a Community Clinic. Community Mental Health Journal. 45(1). 73–77. 17 indexed citations
9.
Bastiaens, Leo. (2007). Effectiveness and tolerability of atomoxetine in a real-world ADHD population: nonrandomized comparison with stimulants.. PubMed. 4(12). 44–8. 7 indexed citations
10.
Bastiaens, Leo. (2006). Youth Aggression: Economic Impact, Causes, Prevention, and Treatment. ˜The œPsychiatric times. 23(11). 36–36. 6 indexed citations
11.
Bastiaens, Leo. (2005). Adolescents? Response to Antidepressant Treatment in a Community Mental Health Center. Community Mental Health Journal. 41(1). 77–84. 1 indexed citations
12.
Bastiaens, Leo, et al.. (2005). Quality of life of children and adolescents: during psychiatric treatment in a community mental health setting.. PubMed. 2(8). 32–5. 4 indexed citations
13.
Bastiaens, Leo. (2004). Response to Antidepressant Treatment in a Community Mental Health Center. Community Mental Health Journal. 40(6). 561–567. 4 indexed citations
14.
Bastiaens, Leo. (1998). Pediatric Psychopharmacology in a Capitated Managed Care System: How Do Patients Fare?. Journal of Child and Adolescent Psychopharmacology. 8(2). 115–124. 6 indexed citations
15.
Bastiaens, Leo. (1995). Compliance with Pharmacotherapy in Adolescents: Effects of Patients' and Parents' Knowledge and Attitudes toward Treatment. Journal of Child and Adolescent Psychopharmacology. 5(1). 39–48. 20 indexed citations
16.
Bastiaens, Leo, et al.. (1993). A manual of psychiatric medications for teenagers.. Journal of Child and Adolescent Psychopharmacology. 3 indexed citations
17.
Bastiaens, Leo. (1992). Knowledge, Expectations, and Attitudes of Hospitalized Children and Adolescents in Psychopharmacological Treatment. Journal of Child and Adolescent Psychopharmacology. 2(3). 157–171. 9 indexed citations
18.
Bastiaens, Leo. (1992). The Impact of an Intensive Educational Program on Knowledge, Attitudes, and Side Effects of Psychotropic Medications Among Adolescent Inpatients. Journal of Child and Adolescent Psychopharmacology. 2(4). 249–258. 10 indexed citations
19.
Davidson, Michael, et al.. (1988). Endocrine Changes in Alzheimer’s Disease. Neurologic Clinics. 6(1). 149–157. 5 indexed citations
20.
Davidson, Michael, et al.. (1988). Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjects. American Journal of Psychiatry. 145(8). 1007–1009. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026